Gene: ARHGAP5
Official Full Name: Rho GTPase activating protein 5provided by HGNC
Gene Summary: Rho GTPase activating protein 5 negatively regulates RHO GTPases, a family which may mediate cytoskeleton changes by stimulating the hydrolysis of bound GTP. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38924 | ARHGAP5 Knockout cell line (HeLa) | Human | ARHGAP5 | 1:3~1:6 | Negative | Online Inquiry |
KO38925 | ARHGAP5 Knockout cell line (HCT 116) | Human | ARHGAP5 | 1:2~1:4 | Negative | Online Inquiry |
KO38926 | ARHGAP5 Knockout cell line (HEK293) | Human | ARHGAP5 | 1:3~1:6 | Negative | Online Inquiry |
KO38927 | ARHGAP5 Knockout cell line (A549) | Human | ARHGAP5 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP5 Gene Knockout Cell Lines are genetically engineered cell lines that have undergone targeted disruption of the ARHGAP5 gene, which encodes a member of the Rho GTPase-activating protein family. This gene plays a crucial role in regulating the Rho/ROCK signaling pathways, influencing cellular processes such as cytoskeletal dynamics, migration, and proliferation. By knocking out the ARHGAP5 gene, these cell lines enable researchers to elucidate the specific functions and biological processes facilitated by this protein, providing a powerful tool for genetic and cellular studies.
The primary mechanism of action relies on the lack of ARHGAP5 protein expression, leading to altered Rho GTPase activity and subsequent changes in cellular behavior. For instance, the knockout of ARHGAP5 has been associated with enhanced migratory capabilities in various cell types, making it a valuable model for investigating cancer metastasis and tissue regeneration. In research settings, these cell lines allow for detailed investigation into gene function, signaling pathways, and cellular responses under various conditions, serving as a pivotal resource for advancing our understanding of cellular biology.
In clinical contexts, the insights gained from studies utilizing ARHGAP5 knockout cell lines can translate into potential therapeutic targets and strategies, especially in oncology and developmental biology. Compared to alternative models, such as transient knockdown techniques or wild-type cell lines, knockout cell lines offer a stable, reproducible platform for long-term studies with clear genetic perturbations.
The value of ARHGAP5 Gene Knockout Cell Lines lies in their ability to facilitate groundbreaking research and discovery, especially for those focused on cellular mechanisms in disease states. For researchers and clinicians seeking to innovate in their respective fields, these cell lines provide a highly valuable asset. With a commitment to quality and cutting-edge genetic technologies, our company stands at the forefront of biological research, offering products that empower scientists to push the boundaries of knowledge and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.